Interleukin‐1α stimulates non‐amyloidogenic pathway by α‐secretase (ADAM‐10 and ADAM‐17) cleavage of APP in human astrocytic cells involving p38 MAP kinase
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Interleukin‐1α (IL‐1α) stimulates a disintegrin and metalloproteinase, ADAM‐17 synthesis, consistent with activation of the soluble fragment of Amyloid Precursor Protein, APP, (sAPPα) in human primary astrocytes. To characterize the mechanism by which IL‐1α promotes the non‐amyloidogenic pathway of APP metabolism, we used U373 MG astrocytoma cells. IL‐1α significantly increased levels of ADAM‐10 and ADAM‐17 mRNA in 16 hr. Upregulation of ADAM‐17 mRNA by IL‐1α was more pronounced despite higher basal levels of ADAM‐10 mRNA. This pattern was also observed at the protein level with the upregulation of α‐secretase. RNA interference (RNAi) of ADAM‐10 and ADAM‐17 inhibited IL‐1α‐stimulated sAPPα release and the effect was more pronounced with ADAM‐17 RNAi. Concomitantly, the level of sAPPα was significantly increased by IL‐1α in 48 hr; however, IL‐1α stimulated cell‐associated APP levels maximally at 6 h but the induction declined at 48 hr. IL‐1α treatment of cells for 48 h reduced both intracellular and secreted levels of amyloid‐β, Aβ‐40, and Aβ‐42 peptides. Multiple MAP kinases (MAPK), including MEK/ERK, p38 kinase, PI3 kinase (PI3K) but not JNK were involved in the regulation of IL‐1α‐stimulated α‐secretase activity and sAPPα release. p38 MAPK seems to be the most proximal of these MAPKs, as it was the earliest to be activated by IL‐1α and blocking this pathway attenuated activation of IL‐1α‐induced MEK and PI3K pathways. Our data show a complex mechanism of sAPPα regulation by IL‐1α that involves ADAM‐10, ADAM‐17 and p38 MAPK upstream of MEK and PI3K. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731 · cited 1×
“Levels of Ab-peptide were measured (in 96-well plates) using the standard sandwich ELISA assay that used 2G3 and 21F12 as capture antibodies for Ab-40 and Ab42 assays respectively (Seubert et al., 1992; Johnson et al., 1997; Baulac et al., 2003), and 266B antibody was used for detection.”
MethodLow cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10
Kojro, E., Gimpl, G., Lammich, S., März, W., & Fahrenholz, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081612998 · Cited by 804
Rogers, J. T., Leiter, L. M., McPhee, J., Cahill, C. M., Zhan, S.-S., Potter, H., & Nilsson, L. N. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6421 · Cited by 290 · cited 2×
“IL-1a also increases Journal of Neuroscience Research DOI 10.1002/jnr cell-associated APP levels, supporting the observation by Rogers et al. (1999), where the primary inflammatory cytokine enhanced APP gene expression at the translational level through the well characterized IL-1 responsive…”
BackgroundSelf-citationBlasko, I., Veerhuis, R., Stampfer-Kountchev, M., Saurwein-Teissl, M., Eikelenboom, P., & Grubeck-Loebenstein, B. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0321 · Cited by 258
Kojro, E., Postina, R., Buro, C., Meiringer, C., Gehrig‐Burger, K., & Fahrenholz, F. (2006) · The FASEB Journal · doi:10.1096/fj.05-4812fje · Cited by 118 · cited 1×
“DOI: 10.1002/jnr.20864 Journal of Neuroscience Research 84:106–118 (2006) ' 2006 Wiley-Liss, Inc. tase cleavage of APP to generate sAPPa is a promising approach to treat AD (Kojro et al., 2006).”
BackgroundInfluential
Cited by
Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., Oh, K. W., & Hong, J. T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-37 · Cited by 772
Adolfsson, O., Pihlgren, M., Toni, N., Varisco, Y., Buccarello, A. L., Antoniello, K., Lohmann, S., Piorkowska, K., Gafner, V., Atwal, J. K., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4742-11.2012 · Cited by 317
Impact of Cytokines and Chemokines on Alzheimer’s Disease Neuropathological Hallmarks
Domingues, C., da Cruz e Silva, O. A. B., & Henriques, A. G. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170317113606 · Cited by 203
Obesity, leptin, and Alzheimer's disease
Lee, E. B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06274.x · Cited by 126
Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease
Ray, B., Maloney, B., Sambamurti, K., Karnati, H. K., Nelson, P. T., Greig, N. H., & Lahiri, D. K. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0709-x · Cited by 91
Self-citation
Metadata
- Authors
- Bandyopadhyay, S., Hartley, D. M., Cahill, C. M., Lahiri, D. K., Chattopadhyay, N., & Rogers, J. T.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2006-05-24
- Volume
- 84
- Issue
- 1
- Pages
- 106-118
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2171947909
- Cited by
- 63
- References
- 6
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.